5,6 %HIV prevalence was significantly higher in females (5.6%) than males (3.7%) aged 15 years and older in the Akwa Ibom AIDS Indicator Survey.
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 4 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
8 823 evidences · page 158 / 353
5,6 %HIV prevalence was significantly higher in females (5.6%) than males (3.7%) aged 15 years and older in the Akwa Ibom AIDS Indicator Survey.
NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 4 observations
39 000 000 peopleAt the end of 2022, 39.0 million people were living with HIV worldwide.
NigeriaVIH/sidaobservé 2022publié 2024BMC infectious diseasesPubMeddocument de 4 observations
26,2 per_100000Cervical cancer is the second most common cancer amongst women in Nigeria, with an incidence rate of 26.2 per 100,000.
Nigeriacancer du col de l'utéruspublié 2025The Pan African medical journalPubMeddocument de 10 observations
53,3 %Among 300 non-diabetic respondents in a cross-sectional survey, 160 (53.3%) were at high risk of developing type 2 diabetes.
Nigeriadiabète de type 2publié 2021African health sciencesPubMeddocument de 10 observations
592 casesFrom 2016 to 2018 in Egor, Oredo, and Uhunmwonde LGAs of Edo state, Nigeria, 592 (57.6%) of the 1,045 new cancers were in females.
Nigeriacancer (non précisé)observé 2016 to 2018publié 2024BMC public healthPubMeddocument de 8 observations
Gametocyte densities were significantly higher by days 3–7 following treatment compared with pre-treatment among children treated with amodiaquine for uncomplicated Plasmodium falciparum malaria.
Nigeriapaludismeobservé 2000 - 2006publié 2008Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/1475-2875-7-169
70,5 %Among medical doctors in Ebonyi state, Nigeria, 70.5% had fair knowledge of the 2015 National Guidelines for Diagnosis and Treatment of Malaria.
Nigeriapaludismeobservé 2019publié 2021PloS onePubMeddocument de 11 observations
45,33 %45.33% of participants recognized fever with shivering/sweating as the most common malaria symptom.
Nigeriapaludismepublié 2025Scientific reportsPubMeddocument de 14 observations
9,9 %The hepatitis B prevalence in conflict zones in Nigeria was 9.9%.
Nigeriahépatite Bobservé 2018publié 2021Annals of global healthPubMeddocument de 12 observations
100 %Sensitivity and specificity for 24-hour HIV viral load testing using BD Vacutainer PPT were both 100%.
NigeriaVIH/sidapublié 2025The journal of applied laboratory medicinePubMeddocument de 3 observations
87 %Retinal reattachment rate was 87% for PVR D eyes.
Nigeriaproliferative vitreoretinopathyobservé 2005–2012publié 2020Nigerian journal of clinical practicePubMeddocument de 11 observations
100 %Days 14 and 28 parasitologic cure rates were 100% (34 of 34) and 96.2% (25 of 26) for children treated with dihydroartemisinin suppository.
Nigeriapaludismepublié 2007The American journal of tropical medicine and hygieneeurope_pmcdocument de 2 observationsDOI 10.4269/ajtmh.2007.76.1
31 %Among 436 treatment-naïve Nigerian breast cancer patients, 31% had luminal A breast cancer.
Nigerialuminal A breast cancerpublié 2026Breast cancer research and treatmentPubMeddocument de 14 observations
42,7 %The prevalence of HbAA without alpha gene deletion was 42.7% among healthy controls.
NigeriaHbAApublié 2022Mediterranean journal of hematology and infectious diseaseseurope_pmcdocument de 17 observationsDOI 10.4084/mjhid.2022.001
53 %A review of January to September 2021 showed a test positivity rate (TPR) decline from 53% to 50% at Secondary Health Facilities (SHFs).
Nigeriapaludismeobservé January to September 2021publié 2025Malaria journalPubMeddocument de 9 observations
All clinics continued to receive support for first and second line antiretrovirals and CD4 testing after the PEPFAR policy change.
NigeriaVIH/sidaobservé October 2014–September 2015publié 2019PloS onePubMeddocument de 11 observations
37 participantsAll 37 participants at week 48 were fully or mostly satisfied with the intervention among youth with HIV in Nigeria in a single-arm trial.
NigeriaVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 12 observations
23,7 %Awareness of the malaria vaccine was low, with only 89 mothers (23.7%) reporting prior knowledge of it.
Nigeriapaludismepublié 2025BMJ openPubMeddocument de 4 observations
10 %The age- and sex-standardised prevalence of chronic kidney disease (CKD) among antiretroviral therapy (ART)-naïve people living with HIV (PLWH) in Lagos, Nigeria ranged from 10.0% to 17.6%.
Nigeriamaladie rénale chroniquepublié 2024BMC nephrologyPubMeddocument de 15 observations
3,2 %Only 3.2% of women in urban slums of Lagos, Nigeria had heard of cervical cancer.
Nigeriacancer du col de l'utéruspublié 2022West African journal of medicinePubMeddocument de 13 observations
91 paysLe paludisme est présent dans 91 pays à risque.
NigeriapaludismeHAL · Unilimdocument de 173 observations
73,2 %73.2% of women in Taraba, North-East Nigeria had appropriate knowledge about the nature of cervical cancer.
Nigeriacancer du col de l'utéruspublié 2019Asian Pacific journal of cancer prevention : APJCPPubMeddocument de 6 observations
7,5 %Left ventricular hypertrophy was observed in 7.5%–10% of children with HIV-associated heart disease.
NigeriaHIV-associated heart diseasepublié 2025The Nigerian postgraduate medical journalPubMeddocument de 10 observations
10,4 yearsThe mean age at onset of pubic hair development (Tanner stage PH2) was 10.4 years in girls with haemoglobin AA.
Nigeriahaemoglobin AApublié 2023West African journal of medicinePubMeddocument de 7 observations
113 government_personnelHoward University Global Initiative, Nigeria developed the capacity of 113 top government personnel as Master Trainers on Pharmaceutical Care in HIV/AIDS.
NigeriaVIH/sidapublié 2025Currents in pharmacy teaching & learningPubMeddocument de 9 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.